Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effect of "combined probiotics" to improve the gastrointestinal function and intestinal bacteria flora

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy Assessment of Probiotics Product on Intestinal Health and Immune System Improvement

NCT04903600

Healthy

UNKNOWN NA

Super 13 Pro & Prebiotics on the Human Intestinal Microflora

NCT04043000

Probiotics Prebiotics

COMPLETED NA

The Effect of Survival, Response and Microbiota Change in Different Therapy Under Probiotic Supplement

NCT06998823

Probiotics Cancer, Therapy-Related

RECRUITING NA

Efficacy of Probiotic Against Functional Constipation

NCT06122558

Constipation - Functional

RECRUITING PHASE2

Determination of the Safety and Efficacy of Two Probiotic Strains

NCT06466174

Gastrointestinal Dysfunction

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Probiotics were known to improve gastrointestinal function before. This is a single-blind placebo control clinical study. We will perform gastrointestinal function questionnaire and collect stool as baseline data before the study (0-week). Then healthy subjects will be randomized to two groups.

Experimental: probiotics 1 pack bid for 3 weeks. Probiotics : (AB-kefir)：Lactobacillus acidophilus,Bifidobacterium longum,Lactobacillus paracasei,Lactobacillus rhamnosus,Lactobacillus fermentum,Streptococcus thermophilus,Lactobacillus helveticus,Kluyveromyces fragilis. Other components include starch,oligosaccharide,yeast powder, superior standard spice， calcium pantothenate， VitB1， VitB12， biotin and folic acid.

Placebo group: placebo 1 pack bid for 3 weeks. Placebo: Except the probiotics (AB-kefir),the other components are the same with study group.

Then gastrointestinal function questionnaire and stool collection will be performed at the end of 1st, 2nd, 3rd, and 4th weeks after starting the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Function Intestinal Bacteria Flora

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

probiotics

1 pack bid use for 3 weeks

Group Type EXPERIMENTAL

probiotics

Intervention Type DIETARY_SUPPLEMENT

probiotics 1 pack (2g) bid for three weeks

Placebo

placebo 1pack bid for 3 weeks

Group Type PLACEBO_COMPARATOR

probiotics

Intervention Type DIETARY_SUPPLEMENT

probiotics 1 pack (2g) bid for three weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

probiotics

probiotics 1 pack (2g) bid for three weeks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy people who are aged between 20 and 40 years

Exclusion Criteria

* 1\. People who use probiotics medication and food that can inhibit bacteria growth within one month before the study 2. People who have active infection 3. People who have active or chronic gastro-intestinal disease 4. People who have diarrhea within two weeks before the study 5. People who are drug or alcohol abuser 6. People who are poor compliance

Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes